CSNMINERACAO (CMIN3) Main Indicators
Basic Data - CMIN3
| Company | CSNMINERACAO |
| Corporate Name | CSN MINERAÇÃO S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Nível 2 de Governança Corporativa |
| Activity | Mineração e comercialização de minério de ferro. infraestrutura de transporte portuária; geração de energia e participação em sociedades com objeto social compatível com o da Companhia. |
| Share | CMIN3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 5.23 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 36.07 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Materiais Básicos |
| Subsector | Mineração |
| Segment | Minerais Metálicos |
| Participation Indexes | IBOVESPA, IBRA, IBRX, ICO2, IDIV, IGC, IGCT, IMAT, ITAG, MLCX |
| Updated 11/21/2024 | |
Relative Prices - CMIN3
| Price/Earnings | 7.41 |
| Price/SBV | 3.21 |
| Price/Net Sales | 1.67 |
| Price/CFO | 3.23 |
| Price/FCF | 3.92 |
| Price/Total Assets | 0.83 |
| Price/EBIT | 5.28 |
| Price/Working Capital | 3.94 |
| Price/NCAV | -1.57 |
| EV/EBIT | 4.23 |
| EV/EBITDA | 3.49 |
| EV/Net Sales | 1.34 |
| EV/CFO | 2.59 |
| EV/FCF | 3.14 |
| EV/Total Assets | 0.67 |
| Company Market Cap | R$ 28.69 B |
| Enterprise Value | R$ 22.95 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 5.23 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 20.40% |
| Updated 11/21/2024 | |
Income Statement - CMIN3
| Net Revenue | R$ 17.18 B |
| Gross Result | R$ 8.81 B |
| EBIT | R$ 5.43 B |
| Depreciation and Amortization | - R$ 1.14 B |
| EBITDA | R$ 6.57 B |
| Net Profit | R$ 3.87 B |
| Net Profit/Share | R$ 0.71 |
| Updated 11/12/2024 | |
| Net Revenue | R$ 3.97 B |
| Gross Result | R$ 1.90 B |
| EBIT | R$ 840.46 M |
| Depreciation and Amortization | - R$ 288.29 M |
| EBITDA | R$ 1.13 B |
| Net Profit | R$ 446.31 M |
| Profit/Share | R$ 0.08 |
| Updated 11/12/2024 | |
Price and Volume Behavior - CMIN3
| Lowest Price 52 weeks | R$ 4.32 |
| Highest Price 52 weeks | R$ 7.13 |
| Variation 2024 | -25.70% |
| Variation 1 year | -13.81% |
| Variation 2 years(total) | 86.97% |
| Variation 2 years(yearly) | 36.62% |
| Variation 3 years(total) | 42.43% |
| Variation 3 years(yearly) | 12.50% |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 68.04 M |
| Updated 11/21/2024 | |
Returns and Margins - CMIN3
| Return on Initial Tangible Capital | 34.08% |
| Return on Initial Invested Capital | 38.65% |
| Pre-Tax Return on Initial Tangible Capital | 51.64% |
| Pre-Tax Return on Initial Invested Capital | 58.56% |
| Return on Initial Shareholder´s Equity | 33.82% |
| Return on Initial Asset | 13.06% |
| Gross Margin | 51.31% |
| Net Margin | 22.53% |
| EBIT Margin | 31.60% |
| EBITDA Margin | 38.25% |
| Initial Asset Turnover | 0.58 |
| Financial Leverage | 3.85 |
| Liabilities/Net Worth | 2.85 |
| Net Debt/EBITDA | -0.87 |
| Updated 11/12/2024 | |
Balance Sheet - CMIN3
| Cash and Cash Equivalents | R$ 14.48 B |
| Total Assets | R$ 34.46 B |
| Short-Term Debt | R$ 1.20 B |
| Long-Term Debt | R$ 7.54 B |
| Gross Debt | R$ 8.74 B |
| Net Debt | - R$ 5.74 B |
| Shareholder´s Equity | R$ 8.95 B |
| Share Book Value | R$ 1.65 |
| Common Shares | 5,432,044,538 |
| Preferred Shares | 0 |
| Total | 5,432,044,538 |
| Common Shares in Treasury | 53,294,300 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 53,294,300 |
| Common Shares (Except Treasury) | 5,378,750,238 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 5,378,750,238 |
| Updated 11/12/2024 | |
Cash Flow - CMIN3
| Operating Cash Flow | R$ 8.88 B |
| Cash Flow from Investments | - R$ 1.56 B |
| Financing Cash Flow | - R$ 3.47 B |
| Increase (Reduction) in Cash and Equivalents | R$ 3.86 B |
| Updated 11/12/2024 | |
| Operating Cash Flow | R$ 3.56 B |
| Cash Flow from Investments | - R$ 475.71 M |
| Financing Cash Flow | - R$ 370.78 M |
| Increase (Reduction) in Cash and Equivalents | R$ 2.71 B |
| Updated 11/12/2024 | |
Experimental - CMIN3
| CAPEX 3 months | - R$ 475.35 M |
| Free Cash Flow 3 months | R$ 3.09 B |
| CAPEX 12 months | - R$ 1.56 B |
| Free Cash Flow 12 months | R$ 7.31 B |
| Updated 11/12/2024 | |